Physiologically Based Pharmacokinetic Modeling of Impaired Carboxylesterase-1 Activity: Effects on Oseltamivir Disposition
出版年份 2014 全文链接
标题
Physiologically Based Pharmacokinetic Modeling of Impaired Carboxylesterase-1 Activity: Effects on Oseltamivir Disposition
作者
关键词
Clopidogrel, Methylphenidate, Oseltamivir, Substrate Drug, PBPK Model
出版物
CLINICAL PHARMACOKINETICS
Volume 53, Issue 9, Pages 825-836
出版商
Springer Nature
发表日期
2014-08-07
DOI
10.1007/s40262-014-0160-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of alcohol-dependent clopidogrel metabolites using conventional liquid chromatography/triple quadrupole mass spectrometry
- (2014) Zhe-Yi Hu et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Physiologically based pharmacokinetic modelling andin vivo[I]/Kiaccurately predict P-glycoprotein-mediated drug-drug interactions with dabigatran etexilate
- (2013) Yuansheng Zhao et al. BRITISH JOURNAL OF PHARMACOLOGY
- Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding
- (2013) Guillaume Paré et al. CIRCULATION
- Towards Quantitation of the Effects of Renal Impairment and Probenecid Inhibition on Kidney Uptake and Efflux Transporters, Using Physiologically Based Pharmacokinetic Modelling and Simulations
- (2013) Vicky Hsu et al. CLINICAL PHARMACOKINETICS
- Evaluation of Various Static In Vitro–In Vivo Extrapolation Models for Risk Assessment of the CYP3A Inhibition Potential of an Investigational Drug
- (2013) Md L T Vieira et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Evaluation of Various Static and Dynamic Modeling Methods to Predict Clinical CYP3A Induction Using In Vitro CYP3A4 mRNA Induction Data
- (2013) H J Einolf et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Evaluation of the Inhibitory Effects of Antihypertensive Drugs on Human Carboxylesterase In Vitro
- (2013) Xu Yanjiao et al. Drug Metabolism and Pharmacokinetics
- Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis
- (2013) Mark Jones et al. DRUG SAFETY
- Modulation of Esterified Drug Metabolism by Tanshinones from Salvia miltiorrhiza (“Danshen”)
- (2013) M. Jason Hatfield et al. JOURNAL OF NATURAL PRODUCTS
- The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?
- (2013) S. Casey Laizure et al. PHARMACOTHERAPY
- Safety, Tolerability, and Pharmacokinetics of Intravenous Oseltamivir: Single- and Multiple-Dose Phase I Studies with Healthy Volunteers
- (2012) Barbara J. Brennan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors
- (2012) Lyudmila G. Tsurkan et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Carboxylesterase 1 Polymorphism Impairs Oseltamivir Bioactivation in Humans
- (2012) E K Tarkiainen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Physiologically Based Pharmacokinetics Joined With In Vitro–In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology
- (2012) A Rostami-Hodjegan CLINICAL PHARMACOLOGY & THERAPEUTICS
- Intestinal Absorption and Presystemic Elimination of Various Chemical Constituents Present in GBE50 Extract, a Standardized Extract of Ginkgo biloba Leaves
- (2012) Li Li et al. CURRENT DRUG METABOLISM
- CYP2C metabolism of oral antidiabetic drugs - impact on pharmacokinetics, drug interactions and pharmacogenetic aspects
- (2012) Andreas Holstein et al. Expert Opinion on Drug Metabolism & Toxicology
- Simple and sensitive assay for quantification of oseltamivir and its active metabolite oseltamivir carboxylate in human plasma using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry: Improved applicability to pharmacokinetic study
- (2012) Zhe-Yi Hu et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Species Difference of Esterase Expression and Hydrolase Activity in Plasma
- (2012) Fatma Goksin Bahar et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response
- (2012) Joshua P. Lewis et al. Pharmacogenetics and Genomics
- Development of a Physiologically Based Model for Oseltamivir and Simulation of Pharmacokinetics in Neonates and Infants
- (2011) Neil Parrott et al. CLINICAL PHARMACOKINETICS
- Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, Part 1: Oral solutions
- (2011) Kirstin Thelen et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Evolution of a Detailed Physiological Model to Simulate the Gastrointestinal Transit and Absorption Process in Humans, Part II: Extension to Describe Performance of Solid Dosage Forms
- (2011) Kirstin Thelen et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Prediction and In Vitro Evaluation of Selected Protease Inhibitor Antiviral Drugs as Inhibitors of Carboxylesterase 1: A Potential Source of Drug-Drug Interactions
- (2011) Jenna A. Rhoades et al. PHARMACEUTICAL RESEARCH
- Predictions of Metabolic Drug-Drug Interactions Using Physiologically Based Modelling
- (2010) Nathalie Perdaems et al. CLINICAL PHARMACOKINETICS
- Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review
- (2010) P Zhao et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: Potential sources of metabolic drug interactions
- (2010) Hao-Jie Zhu et al. TOXICOLOGY
- The Effect of Ethanol on Oral Cocaine Pharmacokinetics Reveals an Unrecognized Class of Ethanol-Mediated Drug Interactions
- (2009) R. B. Parker et al. DRUG METABOLISM AND DISPOSITION
- IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding
- (2009) R. Z. Cer et al. NUCLEIC ACIDS RESEARCH
- Use of Physiologically Based Biokinetic (PBBK) Modeling to Study Estragole Bioactivation and Detoxification in Humans as Compared with Male Rats
- (2009) Ans Punt et al. TOXICOLOGICAL SCIENCES
- Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular Basis
- (2008) Hao-Jie Zhu et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Pharmacokinetics of High-Dose Oseltamivir in Healthy Volunteers
- (2008) Y. Wattanagoon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activation of the Antiviral Prodrug Oseltamivir Is Impaired by Two Newly Identified Carboxylesterase 1 Variants
- (2008) H.-J. Zhu et al. DRUG METABOLISM AND DISPOSITION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now